Safety and effectiveness of natalizumab: The 2-year interim results of the post-marketing surveillance in Japan

Authors :: Takahiko Saida
Y. Ling
K. Yokoyama
Y. Iizuka
Shinichi Torii
H. Makioka
Masakazu Hase
R. Sato
Source :: Journal of the Neurological Sciences. 381:1069-1070
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Natalizumab
Neurology
business.industry
Interim
Postmarketing surveillance
Medicine
Neurology (clinical)
Medical emergency
business
medicine.disease
medicine.drug

Full Text Access

Tools